Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06958523 · ClinicalTrials.gov registry record
Apple Health Study
A clinical trial of Aging and Sleep, sponsored by Apple.
- Recruiting
- Registry status
- 500,000
- Enrollment target
- 2
- Study locations
NCT06958523: Recruiting study of Aging and Sleep, sponsored by Apple.
NCT06958523 is a study of Aging and Sleep that is actively recruiting participants, run by Apple. The registered enrollment target is 500,000 participants, above the 286-participant average among 262 other Aging trials with a reported enrollment target (174725% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06958523, a study of Aging and Sleep, is actively recruiting participants, sponsored by Apple.
- RECRUITING
- Registry status
- 500,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Apple Health Study aims to build a diverse and inclusive group of participants to help researchers advance our understanding of how signals and information collected from apps and devices relate to health and may be used to predict, detect, monitor, and manage changes in health. To enroll, US residents who have an iPhone can download the Apple Research app from the App Store and go through the introduction and informed consent for the Apple Health Study. This study is fully remote, and all are invited to enroll if the eligibility criteria are met. Participants will be asked to complete tasks and surveys, using their iPhone and Apple Research app which include: * Selecting the types of data they would like to share with the study such as health and sensor data * Completing tasks and surveys including areas such as personal demographic information, personal medical history, family history, and social determinants of health
Primary Outcome
Assessed by participant self-report as well as clinical health records and claims data. The initial count and change over time in the number and type of health conditions such as cardiovascular, circulatory, cognition, hearing, mental health, metabolic, mobility, neurologic, respiratory, sex and gender, reproduction, hormones, sleep, and health events such as hospitalizations, procedures or falls.
Conditions Studied
Study Locations (2)
District of Columbia
- MCRA - Washington D.C.
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500,000 participants |
| Start Date | 2025-02-12 |
| Est. Completion | 2030-02 |
What NCT06958523 shows while recruiting
NCT06958523 is an observational study that tracks outcomes without assigning an intervention. Its 500,000 participants enrollment target places it among the larger protocols in the corpus, above the 286-participant average among 262 other Aging trials with a reported enrollment target (174725% higher).
The record links to 10 conditions, with Aging appearing as the primary indexed condition, and to 0 interventions.
NCT06958523 reports a single indexed study location in District of Columbia, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06958523 about?
NCT06958523 is a clinical study titled "Apple Health Study". The Apple Health Study aims to build a diverse and inclusive group of participants to help researchers advance our understanding of how signals and information collected from apps and devices relate to health and may be used to predict, detect, monitor, and manage changes in health. To enroll, US r...
What is the current status of trial NCT06958523?
This trial is currently recruiting. The enrollment target is 500,000 participants. The study started on 2025-02-12. Estimated completion is 2030-02.
What conditions does trial NCT06958523 study?
This clinical trial studies the following conditions: Aging, Sleep, Mental Health, Exercise, Metabolic Health.
Who is sponsoring clinical trial NCT06958523?
This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06958523 being conducted?
This trial has 2 study locations across District of Columbia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06958523's enrollment target sits among peer trials
500,000 1st of 262 higher than 262 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065060 · 500,000 participants
Parkinson Progression Marker Initiative Online (PPMI Online)
- NCT06017687 · 500,000 participants · NA
Data Collection and Evaluation of OptiBP Under Investigational Use
- NCT06342375 · 425,000 participants · NA
Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
- NCT06934239 · 400,000 participants · Phase 4
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI